NCT01251848View on ClinicalTrials.gov

Drug Interaction Between Ritonavir And Sitaxsentan

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2011

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Sitaxentan

Sitaxsentan Tablet, 100 mg, q24h (once daily) for 5 days.

DRUG

Ritonavir

Ritonavir Capsule, 100 mg, q12h (twice daily) for 5 days (morning dose only on Day 5).

DRUG

Sitaxsentan

Sitaxsentan Tablet, 100 mg, q24h (once daily) for 5 days

DRUG

Ritonavir

Ritonavir Capsule, 100 mg, q12h (twice daily) for 5 days

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY